Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. - Wikidata - wikimedia - TriplyDB

Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.

Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.

http://www.wikidata.org/entity/Q34968934

about

Delivery of host cell-directed therapeutics for intracellular pathogen clearance Biosensors with built-in biomolecular logic gates for practical applications Synthetic Nanoparticles for Vaccines and Immunotherapy Near-infrared-induced heating of confined water in polymeric particles for efficient payload release.Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics.Synthesis of polysaccharide-block-polypeptide copolymer for potential co-delivery of drug and plasmid DNA.New class of biodegradable polymers formed from reactions of an inorganic functional group.Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Modified dextran, heparin-based triggered release microspheres for cardiovascular delivery of therapeutic drugs using protamine as a stimulus.Aerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.Engineering nano- and microparticles to tune immunity In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.Chemoselective ligation in the functionalization of polysaccharide-based particles.Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways.Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles Designing polymeric particles for antigen delivery.Recent advances in stimuli-responsive degradable block copolymer micelles: synthesis and controlled drug delivery applications.Biologically responsive polymeric nanoparticles for drug delivery.Smart chemistry in polymeric nanomedicine.Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Inflammation responsive logic gate nanoparticles for the delivery of proteins.An investigation of scavenger receptor A mediated leukocyte binding to polyanionic and uncharged polymer hydrogels.Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.Biorthogonal click chemistry on poly(lactic-co-glycolic acid)-polymeric particles.Dextran-based therapeutic nanoparticles for hepatic drug delivery.Acid-degradable solid-walled microcapsules for pH-responsive burst-release drug delivery.Multiresponse strategies to modulate burst degradation and release from nanoparticles.

P2860

Q27006858-57B7ECC0-57C6-4D7B-841A-C19B9E739279 Q28081299-185D3CFA-D6E4-4F14-A58A-FDF70D680E68 Q28085375-4F76AC3F-7053-4407-BDA2-3F32F688E5FE Q30415679-E7F1B720-60C2-4FA1-A8AB-3F94AD9E03AC Q33583948-5BFA7D12-1E16-45B3-8441-1996CC52DA57 Q33703757-E9332777-89BC-4263-9470-77D05EEF05CB Q33901007-0D341D81-0FC4-4716-B295-6C3278173459 Q34450753-C811518F-0750-44E5-8148-371237F8BD31 Q34509079-2118653E-8287-4B13-90AD-C77E4CE87552 Q34564854-8BEB30F0-1AB7-45BA-A879-EEE6BE93346C Q35155064-5E69A035-381F-4CE9-B2D5-DF0F454553F3 Q35575232-4C3B17E3-6FF9-4BED-A3F1-154ECCBFC32C Q35851497-7BB34C42-EA40-4C38-BFC1-309DD817791A Q36047076-0D6F4975-6368-4468-BDDF-5B011E51DC3B Q36122915-47D55925-3047-41A3-BC66-672EFCA71F6C Q36354901-424AAB54-15B9-4080-BF8D-8895A56442E6 Q36630649-9FE0FD35-2ED9-4E4F-B6CA-623A9CB698A7 Q37205125-42CC58CF-7433-480C-BF7D-DD4198FC7264 Q37317946-ADBDFB4B-660E-48B8-8301-FA1977EC26F6 Q37378031-1E4DC73F-A03B-49AA-8EDC-F060F0C9AB92 Q37381177-A68732E6-2A1F-4237-A5AF-EF61C7E814E8 Q37542987-191128DE-7D94-4021-B8C3-62AE07D30AE2 Q37684900-3922D1A3-A700-4E7E-AE2C-04E6A5A5D513 Q37714122-7D2DE269-9ADD-487B-BD12-805D0C4E6DC0 Q37808118-0B6F8310-3CD2-4F66-A716-855CFB963E9F Q38022037-306116CB-3002-4DEC-97E0-377C21F44F3C Q38044396-C81B921D-6ABF-4F85-8798-DCF271D66EC9 Q38221776-CB8CB117-8DE7-4ACC-9116-4052A097B906 Q38641613-2310F307-A7D3-4376-9D50-FC6A56FC85DC Q38676164-DA6AFBE1-23F3-4A39-A88D-AE22EF590A4D Q38749645-AE8A130C-7209-497C-8860-F5D09EADC25A Q38816102-FD842A5E-DBBC-4D0D-A464-AED0A8D4B096 Q38912004-0DA4F7B3-5FB1-4A2D-89BE-FBA1A5DF5536 Q38914284-95A101A9-9151-436F-9C10-DDF5BFCD2071 Q38969200-F7CE98BD-AF98-49B7-9200-EF696A0CD870 Q38974572-043CA8FF-543D-4B63-A434-54A6080B3933 Q39096259-00824649-E9B9-42F8-802A-9808D4C7DB11 Q39390586-AB352853-13A2-4ABD-BB7C-596AA5AF4770 Q39626484-0BB54D28-7F0B-4227-BA86-6ED52B9C79EA Q39657677-6BA57CAC-3222-4920-BF09-230D0CBF59A6

P2860

Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.

http://www.wikidata.org/entity/Q34968934

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@ast

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@en

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@nl

type

label

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@ast

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@en

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@nl

prefLabel

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@ast

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@en

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@nl

P1433

Q34968934-4A29B446-95CA-481E-820B-10B6C1A0C4DE

P1476

Q34968934-64FD8109-BEBD-45B3-8D18-F50D7EE874AF

P2093

Q34968934-1C151C7B-E91F-48D2-A9B4-DBEECAAD31B0

Q34968934-B3F85F8A-88F0-4B4E-AF77-BE14E6C23200

Q34968934-C1B07229-BAC0-48C6-B94E-94E7A4264542

P2860

Q34968934-06E82769-E18B-432F-A5E4-D4D4F4CAE192

Q34968934-18C16914-ECB3-49C7-B258-BA27503F1904

Q34968934-21DBB438-6DDB-4D74-8706-2848EBB6FAB7

Q34968934-268FDAAF-1E29-43EA-9D56-CA1FB8C2EAA2

Q34968934-29B1DA11-8B0B-4C7D-B8FC-E1FA26858F6B

Q34968934-4CC1F5A7-CAC9-4BD3-8ABF-2E669A99B770

Q34968934-4E6D6B2D-A2AC-4EFC-A985-25524473B887

Q34968934-61146DA9-FB65-4756-AE83-1A2DAE38D3CB

Q34968934-6478F5FE-CA90-4AD1-BAD2-D249F89FA90F

Q34968934-6DFDEE23-A2B9-4A92-97FC-A65B7D0BF7D0

P304

Q34968934-56754FCC-E01D-415C-A7D0-EF276AC5AA5F

P31

Q34968934-2849160C-D0A3-473A-BDF5-E747443FFAC0

P356

Q34968934-562F29AC-5025-4F7E-8760-EA79766C0F1C

P407

Q34968934-BBF2E1D5-2F3C-4A49-962C-5E05E00C074B

P433

Q34968934-BEFE9172-27BA-4AF7-A1AE-6D6667FDB2B7

P478

Q34968934-4A9A322D-8EE9-45F5-AD49-34389E2C0A71

P50

Q34968934-7D17E47C-F927-49B3-B40D-09F17F916998

Q34968934-F255377D-FCF7-4098-A389-AA660BAF21D9

P577

Q34968934-C0EA2D23-D0B0-4E73-9B59-53EF0B97E76C

P5875

Q34968934-1718173D-B1FB-4392-B2A9-FDF4A575382E

P698

Q34968934-40DFFCD3-129B-477A-A756-DAED0EF0BAF6

P921

Q34968934-F3573CC9-1038-4A87-A752-41D318BE9F36

P932

Q34968934-0F8903B9-FB56-44E7-A690-60E330A79F17

P356

PNAS.0901592106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Acetalated dextran is a chemic ...... for particulate immunotherapy.

@en

P2093

Eric M Bachelder

http://www.w3.org/2001/XMLSchema#string

Joel A Cohen

http://www.w3.org/2001/XMLSchema#string

Tristan T Beaudette

http://www.w3.org/2001/XMLSchema#string

P2860

Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo

Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

Antigen release kinetics in the phagosome are critical to cross-presentation efficiency

Dendritic cells in cancer immunotherapy.

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications

A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

Cross-presentation: underlying mechanisms and role in immune surveillance.

Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.

P304

5497-5502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0901592106

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Kyle E. Broaders

P577

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24234260

http://www.w3.org/2001/XMLSchema#string

P698

19321415

http://www.w3.org/2001/XMLSchema#string

P921

P932

2666992

http://www.w3.org/2001/XMLSchema#string